PALMINAVIR solution is prepared from the tincture of de-lignified extract of date palm leaf (Phoenix dactylifera L.) and the important polyphenolic compounds in this extract, among other compounds, cause antiviral properties.
Palminavir, in addition to routine treatments, improves the inflammatory symptoms in patients with mild to moderate coronary artery disease, reduces the duration of the disease and the length of hospital stay, and is also prescribed to boost the immune system.
The dose of this drug in adults over 12 years, 3 to 5 times a day (depending on the severity of the disease from mild to moderate) each time 5 ml diluted in 30 ml of water for 9 to 14 days.
According to research on animal toxicity, the drug in the specified therapeutic dose has no side effects.
Performed in Ganjavian Hospital, Dezful University of Medical Sciences
Volunteers: 100 patients with mild to moderate COVID19- (50 patients in the drug group and 50 patients in the placebo group)
Dosage in the study: 5 ml in 30 ml of water 5 times a day
Duration of treatment: 9 to 14 days (depending on the severity of COVID19-)